Randomized Phase III Trial Evaluating the Impact of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Relapse free survival
There is a follow-up period of 3 years.
from randomization to relapse or last contact (up to 3 years)
Philippe MORICE, Pr
Gustave Roussy, Cancer Campus, Grand Paris
France: Committee for the Protection of Personnes